Skip to content

Bajaj Healthcare: Weak Q1 not a dampener for long run

Capacity ramp-up and new business opportunities should stand Bajaj Healthcare in good stead; any correction a scope to buy

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish